
Malcolm Potts, Irreverent Evangelist for Contraception, Dies at 90
Malcolm Potts, a physician, reproductive scientist and contraceptive evangelist who helped develop and promote the device most frequently used to perform surgical abortions, and who spent more than half a century directing programs that provide reproductive health services to women in developing countries, died on April 25 at his home in Berkeley, Calif. He was 90.
The cause was Alzheimer's disease, said his stepdaughter, Madison Iler.
Although he didn't identify himself as such, Dr. Potts was essentially a neo-Malthusian. Like Thomas Robert Malthus, the economist of the late 18th and early 19th centuries. he saw population control as critical to preventing war, famine and environmental collapse, particularly in Africa, where for decades he oversaw women's health programs, first as medical director of the International Planned Parenthood Federation and then as president of Family Health International, another global organization. He felt that women's ability to control their own reproductive lives was crucial to that aim — an enormous challenge in the conservative countries he served.
'Malcolm felt we were heading for catastrophe if we didn't do a better job in family planning,' said Stefano Bertozzi, a former dean at the University of California, Berkeley School of Public Health, where Dr. Potts held an endowed chair in population and family planning. The two met when they were working on H.I.V. prevention in Africa for different organizations.
'He was a ferocious ally for women having unfettered access to the tools they needed to manage their own fertility,' Dr. Bertozzi said in an interview.
The British-born Dr. Potts was rumpled, tweedy and irreverent. He was of a generation that did not pander to political correctness, and he had a collection of ties printed with condoms. He was also one of Berkeley's most popular professors. His classes on human sexuality, at which he dispensed policy points, naughty anecdotes and common sense, were filled to overflowing. Dr. Bertozzi called him the Bernie Sanders of Berkeley.
'He was the biggest feminist I ever met — and the most unlikely,' said Alisha Graves, a public-health policy expert and former student of Dr. Potts's. Together the two of them founded OASIS (the initials stand for Organizing to Advance Solutions in the Sahel), an organization that serves women in the Sahel, a region just below the Sahara that encompasses 10 countries and has been battered by climate change, poverty and high rates of fertility — as well as its terrible byproduct, maternal mortality.
Dr. Potts's focus was global, but his first brush with the fallout from unwanted pregnancies happened at home.
A newly minted obstetrician, he was fresh out of medical school at the University of Cambridge when he was posted to a busy hospital in North London. There, he regularly treated women suffering from incomplete abortions — meaning that they were still pregnant, but losing blood.
It was the early 1960s, abortion was not yet legal in England, and, Dr. Potts said, the experience was an epiphany.
He opened a clinic to provide contraception to single women and vasectomies to men. And he joined a lobbying group of medical professionals working for the legalization of abortion in Britain, which happened in 1967.
Dr. Potts became a well-known booster of oral contraceptives; he once told a newspaper reporter that the Pill was so safe, he would give it to his 2-year-old daughter. He famously appeared on David Frost's late-1960s talk show, 'The Frost Programme,' to debate the merits of oral contraceptives with a conservative gynecologist. The gynecologist averred that they were so dangerous, he would prescribe them only to prostitutes. Dr. Potts responded by pouring a bag of rice onto a table and picking out two grains, to indicate the percentage of women at risk of death from taking birth control pills. He then counted out 27 grains to illustrate the percentage of women at risk of dying from an unintended pregnancy.
'It would be a service to mankind if the Pill were available in vending machines and cigarettes were placed on prescription,' Dr. Potts told Reader's Digest in 1969. (It was a sign of the times that cigarettes were then sold in vending machines, like candy.)
In 1968, Dr. Potts became the medical director of the International Planned Parenthood Federation. In that position, he saw firsthand how the low status of women in poor countries led to harsh outcomes in their reproductive health.
He began to research ways to provide safe abortions in places where medical care was delivered in less-than-optimal conditions. He read about Harvey Karman, an eccentric activist and psychologist in training at the University of California, Los Angeles, who had come up with a way of performing abortions that was safer and less painful than what was then the more frequently used method, dilation and curettage. Vacuum extraction, as the technique is called, is now the most common surgical procedure for ending a pregnancy.
Dr. Potts sought out Mr. Karman, and together they refined the device he invented to perform vacuum extraction. They wrote about it for The Lancet, the British medical journal, whose editors were unaware that Dr. Potts's co-author was not a medical doctor. Dr. Potts received a grant from the United States Agency for International Development to provide the device to International Planned Parenthood Federation clinics around the world.
In 1972, the two men brought the device to Bangladesh, where they were part of a team of medical professionals invited by the government to perform abortions on rape victims and to train local doctors in the procedure. (Some 1,500 women and girls, many as young as 10 years old, had been raped by Pakistani soldiers during the Indo-Pakistan war of 1971, when Bangladesh won its independence.)
In India, Dr. Potts traveled to Mumbai (then known as Bombay) to provide vasectomies; he set up a clinic on a train station platform because men there were fearful of hospitals. In Thailand, he organized a community-based distribution system of birth control pills and condoms, training market vendors, shopkeepers, schoolteachers and one undertaker to dispense them properly.
A decade ago, Dr. Potts started a company called Cadence with Nap Hosang, an obstetrician who was his colleague at Berkeley, and Samantha Miller, a pharmaceutical industry veteran, to produce a birth control pill that could be sold without a prescription. After years of holdups by the Food and Drug Administration, exacerbated in recent months by layoffs at the agency, it has yet to be approved.
Zena, as it's called, is a combination progesterone-estrogen pill that carries a low risk of blood clots. (An online questionnaire, should the pill receive the go-ahead, would evaluate each woman's risk.)
The company has been more successful with its Morning After Pill, which is sold online, in convenience stores like 7-Eleven and in vending machines on college campuses.
David Malcolm Potts was born on Jan. 8, 1935, in Sunderland, England, the youngest of three sons of Kathleen (Cole) Potts and Ronald Windle Potts. He grew up in Newcastle and attended Cambridge, where he earned his medical degree and a Ph.D. in embryology.
Dr. Potts was married four times. His marriages to Dera Joyce Cook and Caroline Merula Deys ended in divorce. His third wife, Marcia Jaffe Potts, died in 1993. His fourth wife, Martha Madison Campbell, died in 2022.
In addition to Ms. Iler, his stepdaughter, Dr. Potts is survived by a son, Oliver Macdonald, from his first marriage; a daughter, Sarah Deyes Longlands, and a son, Henry Potts, from his second; a daughter, Sandra Potts Jaffe, from his third; two stepsons, Douglas Iler and Bruce Iler; seven grandchildren; and four great-grandchildren.
Dr. Potts was the author of a number of books — not only practical textbooks on contraception, but also quirkier fare, including 'Queen Victoria's Gene: Haemophilia and the Royal Family' (1995), written with his brother William, which suggested that Queen Victoria had been illegitimate. They noted that none of her ancestors had possessed the genetic mutation for hemophilia, which she famously passed along to royalty throughout Europe. Therefore, they argued, her father could not have been Prince Edward.
When the book came out, Dr. Potts told The Sunday Times of London that he thought Queen Victoria's body should be exhumed for DNA testing to settle the matter. A spokesman for the royal family responded, 'I don't think there's been any attempt ever to dig up members of the royal family.'
'Sex and War: How Biology Explains Warfare and Terrorism and Offers a Path to a Safer World' (2008), which Dr. Potts wrote with Thomas Hayden, a journalist, explored what they called the male predisposition to team aggression, tracing it from prehistory and primatology to current horrors.
Educating women and girls to increase the number of women in leadership roles was one of their suggestions for a way to 'help make peace break out.'
'Peace needs strong allies in order to persist,' they wrote, 'and the ally that has been the most consistently overlooked is the one that makes up slightly over half the human race — women.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Health Line
an hour ago
- Health Line
Cannabis Use May Double Risk of Death From Cardiovascular Disease, Study Finds
A new scientific analysis indicates that cannabis use may increase the risk of cardiovascular health issues, including stroke. In an accompanying editorial, two health experts say these risks are serious enough to warrant the regulation of cannabis in the same manner as tobacco. Previous research has reported on the health benefits of cannabis for people with chronic pain and other ailments, but experts say the potential effects of cannabis should be discussed with your doctor. Medical experts are sending out another strong warning about cannabis use and the risk of cardiovascular health issues. In an analysis published in the journal Heart, researchers report heightened risks of stroke, acute coronary syndrome, and death from cardiovascular disease associated with frequent cannabis use. In an accompanying editorial, two health experts say the dangers from cannabis use are serious enough to warrant the substance being regulated much like tobacco. The editorial authors say the warnings are particularly important because the recent widespread legalization of the drug may have convinced many people that cannabis use is safe. 'Frequent cannabis use has increased in several countries, and many users believe that it is a safe and natural way to relieve pain or stress. In contrast, a growing body of evidence links cannabis use to significant harms throughout life, including cardiovascular health of adults,' wrote Stanton Glantz, PhD, an emeritus professor at the University of California San Francisco, and Lynn Silver, MD, a professor in UCSF's Department of Epidemiology and a program director at the Public Health Institute in Oakland, CA. 'Specifically, cannabis should be treated like tobacco: not criminalized but discouraged, with protection of bystanders from secondhand exposure,' the editorial authors added. Robert Page II, PharmD, a professor in the Department of Clinical Pharmacy and the Department of Physical Medicine/Rehabilitation at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, noted the analysis relied on observational studies, but said the message is clear. 'This meta-analysis validates current large observation studies that cannabis should be considered a potential risk factor for premature development of ASCVD (atherosclerotic cardiovascular disease), said Page, who was chair of an American Heart Association writing group that authored a 2020 report on cannabis, medical cannabis, and heart health. Page wasn't involved in the present study. 'If we ignore these signals, we are destined to repeat the fatal history of cigarette smoking, which took years to finally realize its devastating effects on cardiovascular health and mortality,' he told Healthline. Cannabis and heart health In their analysis, researchers looked at 24 studies published between January 2016 and January 2023 that included about 200 million people. The study participants were mostly between the ages of 19 and 59. Cannabis use tended to be more frequent in males and in younger people. The researchers said their analysis of that data revealed that cannabis use doubled the risk of dying from cardiovascular disease. They also reported that people who used cannabis had a 29% higher risk of acute coronary syndrome, a condition that causes sudden reduced or blocked blood flow to the heart, as well as a 20% higher risk of stroke. The researchers acknowledged that many of the studies they analyzed lacked information on missing data and had imprecise measures of cannabis exposure. Most of the studies were also observational. Nonetheless, their analysis comes less than a month after another study concluded that chronic use of cannabis is associated with a higher risk of endothelial dysfunction, a type of non-obstructive coronary artery disease in which there are no heart artery blockages but the large blood vessels on the heart's surface constrict instead of dilating. In addition, another analysis from earlier this year reported that cannabis users were six times more likely to have a heart attack than non-users. A 2024 study concluded that people who use cannabis to treat chronic pain had a higher risk of atrial fibrillation and other forms of heart arrhythmia. The researchers in the new analysis say their findings are particularly important because the use of cannabis has soared in recent years. They also note that the potency of the drug has increased. There was no delineation in the analysis, however, on the risks of smoking cannabis compared to ingesting it. Cheng-Han Chen, MD, an interventional cardiologist and medical director of the Structural Heart Program at MemorialCare Saddleback Medical Center in California, said both methods may present health risks. Chen wasn't involved in the study. 'It is thought that ingesting THC increases systolic absorption of the chemical when compared to smoking THC and thus results in greater adverse effects,' he told Healthline. 'However, cannabis smoke comes with a separate set of health concerns, as the smoke contains many carcinogens and mutagens similar to tobacco smoke.' Ziva Cooper, the director of the UCLA Center for Cannabis and Cannabinoids, said the frequency someone uses cannabis, as well as the dosage, are also important factors. Cooper was likewise not involved in the study. She noted that new research is starting to show there are mental health risks to frequent cannabis use. One of those is cannabis use disorder, a condition that is estimated to affect 30% of people who use the substance. 'There are new risks that are emerging that weren't even on the radar,' Cooper told Healthline. She added cannabis can also impair people's ability to drive as well as impair their cognitive abilities. 'These are things that can affect a person's everyday life,' Cooper said. Defending cannabis use Paul Armentano, the deputy director of NORML, a non-profit that advocates for the responsible use of cannabis, acknowledges there are studies that report health risks associated with cannabis use. Armentano wasn't involved in the study. However, he told Healthline there are others who conclude there is no risk or even a decreased risk of cardiovascular disease from cannabis use. These include a 2023 study, a 2020 study, and a 2023 meta-analysis. 'In short, while tobacco smoke exposure's role in cardiovascular disease is well established, the potential role of cannabis smoke is not,' Armentano said. 'Nonetheless, persons wishing to mitigate their intake of cannabis smoke can do so via the use of herbal vaporizers, which heat cannabinoids to the point of activation but below the point of combustion.' Armentano cited studies in 2006 and 2007 that reported no health effects from vaporization. Some research has reported on some overall health benefits derived from cannabis use. A 2023 study concluded that medical cannabis can improve the quality of life for some people with chronic pain. Other research has reported that cannabis can be helpful to people with depression, social anxiety, and post-traumatic stress disorder (PTSD). There are also indications that cannabis products can help ease the side effects of cancer treatments. Talking with your doctor about cannabis In their editorial, Glantz and Silver encourage medical professionals to become leaders in cannabis education. 'There is an important role for public health and public policy in addressing the risks identified [in the new analysis],' they wrote. 'While the trend toward legalization is established, that does not mean that the risks of cannabis use should be minimized or its use encouraged.' Page said he takes cannabis use into consideration when assessing his patients' cardiovascular health. 'While many of the current cardiovascular risk calculators do not include smoking cannabis into their algorithms, I do include it (just like smoking cigarettes) when assessing patients' cardiovascular risk and consider it just as powerful a risk factor as smoking cigarettes,' he said. Page added that people should be informed about the many potential health issues of cannabis use before deciding whether to use it. 'Know the risks and talk to your primary care provider before considering any use, medical or recreational. Many younger adults feel invincible and have the belief that 'This will not happen to me' or 'I could never develop cannabis use disorder.' However, it does and can occur,' he said. 'For older adults, I caution them regarding potential drug-drug interactions as both THC [tetrahydrocannabinol] and CBD [cannabidiol] can have effects on a large majority of medications, both pharmacokinetically and pharmacodynamically,' Page added. Chen agrees that patients need to educate themselves about cannabis before trying it. 'Any form of cannabis use does involve some risk to your health. Everyone must decide for themselves how much risk they want to expose themselves to,' said Chen. 'I would advise people to avoid smoking cannabis, as the smoke can directly harm the lungs. Also, patients with known pre-existing cardiovascular disease or with cardiovascular risk factors should consider avoiding cannabis use in general, given the potential harm to heart health,' he added. Cooper noted that cannabis has 500 different chemical components, so its effects can vary greatly from person to person.


Forbes
3 hours ago
- Forbes
Ten Years In: True Botanicals Is Proving Clean Beauty Outperforms
Ten years after launching, True Botanicals is still innovating and proving clean beauty is as, if not more, effective than traditional products. When I first wrote about True Botanicals back in 2015, it was a fledging skincare brand with a powerful origin story: its founder, Hillary Peterson, was a cancer survivor on a mission to make safe skincare products that felt luxurious to use and improved skin health. At the time, clean beauty was still somewhat niche, and consumers were just starting to examine the ingredients of their moisturizers and serums. Today, the so-called clean beauty space is crowded and often confusing, rife with greenwashing, cleanwashing, and questionable claims. But True Botanicals stands out from the crowd with first-to-market, science-backed formulations—including one of the first face oils (remarkable since they are now so ubiquitous) and breakthrough ingredients including chebula and peptillium. Peterson is now board chair, having hired CEO Sandy Saputo in 2020. They're both still hyper focused on the brand's original thesis: safe products are just as effective of those that contain potentially toxic ingredients—and in many cases they perform much better. 'We've been on a mission to prove the products that prioritize the health of people and the planet can be the most effective—and we've proven it,' Peterson told me recently. 'We've outperformed leading conventional brands, and opened people's minds to the fact that you don't have to sacrifice results for safety.' Celebrities including Brooke Shields have signed on as spokesmodels for True Botanicals. True Botanicals completed a series B funding round in March 2023, led by growth equity firm NextWorld Evergreen. That helped the brand grow from indie direct-to-consumer brand into one with a loyal following that's sold in major retailers including Nordstrom, The Detox Market, and Erewhon. The funding also helped put in place a new, all-female board, and strengthen its commitment to environmental, social, and governance values. Celebrities including Olivia Wilde, Laura Dern, and Brooke Shields and Jessica Chastain have graced the brand's advertising campaigns Actress Laura Dern has been a spokesmodel for True Botanicals. The company continues to formulate its products in the United States, using independently verified non-toxic ingredients, and remains steadfast in its mission to push back against 'cleanwashing:' when brands use buzzwords like 'clean' without real standards to back them up. For example, a class-action lawsuit launched in 2023 alleges that products with the Target Clean seal actually contained parabens, talc, and PFAS (forever chemicals linked to cancer and immune risks)—ingredients the Target Clean stamp claimed to exclude. The lawsuit is ongoing, and several other class-action lawsuits have proliferated in recent years. True Botanicals relies on third-party testing to prove its claims, including MADE SAFE and Environmental Working Group verified. 'Don't take it from us,' Peterson says. 'Take it from these organizations whose only job is to have the consumer's back.' Hillary Peterson founded True Botanicals in 2015 after surviving a cancer diagnosis. Transparency along with the effectiveness of its products seem to be at the heart of what has allowed the brand to endure. Bringing in Seputio as CEO has also had a big impact. When she signed on, she had decades of experience building purpose-driven beauty brands including Bareminerals and Kendo Brands, and she helped accelerate True Botanical's growth. 'We've quintupled the business in 5 years, and this amazing growth has come from serving our luxury, wellness-driven consumer with relevant innovations in the field of green science that have brought meaningful and intrinsic value to her,' Saputo says. Sandy Saputo joined True Botanicals as CEO in 2020 and has spearheaded significant growth. She credits the brand's innovation mindset, and hints that True Botanicals will soon be first-to-market with a product 'that incorporates a patented dermal delivery system which is a breakthrough for cellular health.' From the beginning, True Botanicals was one of the few brands connecting skincare to wellness, treating the skin as part of the body's larger ecosystem rather than a surface to be treated or fixed. 'When we put products on our skin, we're consuming them,' Peterson says. 'There's no room for toxins in wellness. That should be a given.' As more beauty brands and products have launched with fun packaging, viral TikTok videos, and vague or unproven claims, beauty consumers have gotten much younger. An Ulta Beauty study found that Gen Z Alpha is starting to experiment with beauty products as young as 13, and Gen Alpha at just 8 years old. That means many women and girls are using beauty products for a longer period of time over their lifespan. Peterson credits True Botanicals' all-female board and executive team for bringing a generational mindset to the table. 'I think there is something to the fact that women are community builders,' Peterson says. 'Historically, through millennia, women have taken care of the community. So I think when you have women leading a business like ours, there will be more of a focus on the health of people and in future generations. I mean, I think about future generations all the time: my kids, their kids—what are we going to leave them?' After a decade in business, Peterson has become a mentor where she once was the youngest sibling vying for a place at the table—she was recently awarded the Cosmetic Executive Women Visionary Award. True Botanicals has shown that naturally occurring ingredients can be even more effective than ingredients used in conventional brands. 'Now there's a confidence, not just in the brand, but in our place in the industry.' And what will the next 10 years look like? The brand will continue to research innovative ingredients sourced from nature and harness its regenerative power. 'For instance,' Peterson says, 'the intelligence that supports plants that thrive in the harshest conditions can be equally supportive of our skin's vitality.' Peterson and Saputo are also focused on thoughtful growth, expanding retail partnerships within the United States, deepening customer relationships, and staying grounded in their mission. 'We're not here to chase trends,' Peterson says. 'We're here to create something that lasts.'
Yahoo
4 hours ago
- Yahoo
Northstrive announces initiation of Phase II of AI Development Program
Northstrive Biosciences announced the initiation of Phase II of the AI Development Program with strategic partner Yuva Biosciences. As part of the Phase II objective, both companies will collaborate to leverage MitoNova, YuvaBio's AI mitochondrial science-focused artificial intelligence platform, to compile a selection of small molecule candidates that promote mitochondrial health in obesity and cardiac diseases. YuvaBio will use MitoNova to virtually screen a large-scale library of diverse, drug-like small molecules and predict which candidates are most likely to promote mitochondrial health. YuvaBio will then analyze results of this screen, including chemical and bioactivity properties, to highlight opportunities for biological validation. Then, YuvaBio will compile an initial list of synthetic compounds for muscle preservation and metabolic health. Northstrive Biosciences, a PMGC (ELAB) Holdings, is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on ELAB: Disclaimer & DisclosureReport an Issue PMGC signs LOI to acquire California-based CNC machining company PMGC Holdings Signs LOI for U.S. Electronics Acquisition PMGC signs LOI to acquire electronics contract manufacturing company Northstrive announces completion of Phase 1 research, synthesis for EL-22 Northstrive Biosciences Amends License Agreement with MOA Life Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data